More about

Washington University School Of Medicine In St Louis

News
February 24, 2020
14 min read
Save

Smoking cessation should be ‘pillar’ of the cancer treatment protocol

Smoking cessation should be ‘pillar’ of the cancer treatment protocol

Tobacco use is the leading preventable cause of cancer, responsible for nearly 30% of cancer-related deaths in the U.S. annually.

News
December 30, 2019
7 min read
Save

An emerging industry looks to take T cells to the cryobank

An emerging industry looks to take T cells to the cryobank

An increasing body of evidence shows that using younger, less heavily pretreated T cells results in more effective chimeric antigen receptor T-cell therapies.

News
December 19, 2019
13 min read
Save

Early action required for prevention, management of fatty liver in type 2 diabetes

Early action required for prevention, management of fatty liver in type 2 diabetes

Nonalcoholic fatty liver disease, or NAFLD, a condition traditionally treated by hepatologists, is widespread and frequently associated with obesity, insulin resistance, diabetes and other metabolic risk factors. Type 2 diabetes appears to worsen the course of NAFLD and promote development of nonalcoholic steatohepatitis, or NASH, the more severe form of the disease, as well as increase risks for cirrhosis and hepatocellular carcinoma. Liver disease similarly makes diabetes management more challenging. At least half of all individuals with type 2 diabetes also have NAFLD, setting the stage for a worse metabolic profile and greater cardiovascular risks. Currently, there are no drugs approved to treat NAFLD.

News
September 08, 2019
4 min read
Save

Novel KRAS inhibitor induces disease control in 96% of treated patients with non-small cell lung cancer

Novel KRAS inhibitor induces disease control in 96% of treated patients with non-small cell lung cancer

BARCELONA — AMG 510 appeared well-tolerated and showed promising antitumor activity among patients with locally advanced or metastatic non-small cell lung cancer, with 96% of patients achieving disease control, according to phase 1 study results presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.

News
September 06, 2019
11 min read
Save

New research, recent controversies question vitamin D benefits in CVD

New research, recent controversies question vitamin D benefits in CVD

The idea of “sunshine in a bottle” — vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. It has also been investigated as a strategy for CVD prevention, but results to date have been negative.

News
July 29, 2019
2 min read
Save

Leukemia Research Foundation awards grants to 12 investigators

The Leukemia Research Foundation awarded $1.2 million in research grants.

News
June 17, 2019
3 min watch
Save

VIDEO: More evidence highlights importance of healthy diet for breast cancer survival

VIDEO: More evidence highlights importance of healthy diet for breast cancer survival

CHICAGO — At the ASCO Annual Meeting, Lindsay Peterson, MD, breast medical oncologist at the Washington University School of Medicine, spoke with HemOnc Today about the “important” findings of the Women’s Health Initiative Dietary Modification trial.

News
June 13, 2019
10 min read
Save

Surgeons should educate each other on the hip-spine connection

Surgeons should educate each other on the hip-spine connection

The belief that the spine moves independently of the pelvis and hip has been disproved in recent years as researchers repeatedly identified important connections between the alignment of the spinal column and the position of the pelvis. As a result, the treatment of patients with hip-spine pathology is now headed in a new direction, according to orthopedic surgeons interviewed for this Cover Story.

News
June 01, 2019
2 min read
Save

Proton therapy maintains efficacy, reduces toxicity of radiotherapy for locally advanced cancer

Proton therapy maintains efficacy, reduces toxicity of radiotherapy for locally advanced cancer

CHICAGO — Proton chemoradiotherapy significantly reduced incidence of adverse events associated with unplanned hospitalizations compared with traditional photon chemoradiotherapy among adults with nonmetastatic cancers, according to results of a comparative effectiveness study presented at ASCO Annual Meeting.

News
April 10, 2019
5 min read
Save

Is ibrutinib-based therapy the preferred initial treatment for all patients with CLL?

Is ibrutinib-based therapy the preferred initial treatment for all patients with CLL?

Click here to read the Cover Story, “Advances in chronic lymphocytic leukemia suggest progress is ‘visible on the horizon’.”

View more